Consider Cardiovascular Disease When Recommending Metformin Add-Ons
Cardiovascular impact will be considered more when choosing meds to add to metformin...due to new evidence and updated Canadian guidelines.
We're used to suggesting diabetes meds based on their A1C lowering, side effects, cost, etc. But now CV impact will also be important.
Recent studies show a CV benefit for Jardiance (empagliflozin) and Victoza (liraglutide) in some type 2 diabetes patients.